Volume 29, issue 10, December 2022

ÉDITORIAL

Annus mirabilis or horribilis? From dysplasia to metastatic anal canal cancer: progress that raises many questions (p.1147-54)
Astrid Lièvre, Laurent Siproudhis
Open Access

MINI-REVUES

Microbiota and pancreatic pancer (p.1157-64)
Cindy Neuzillet

Influence of socioeconomic disparities on liver diseases (p.1165-71)
Nga Nguyen, Benjamin Menahem, Thong Dao, Guy Launoy

Radiomics, a promising new discipline : example of hepatocellular carcinoma (p.1172-80)
Thomas Lévi-Strauss, Bettina Tortorici, Olivier Lopez, Philippe Viau, Dann J. Ouizeman, Baptiste Schall, Xavier Adhoute, Olivier Humbert, Patrick Chevallier, Lionel Fillatre, Rodolphe Anty

From scope progression to resection: let’s dive! (p.1183-90)
Marion Schaefer, Jean-Baptiste Chevaux, Jérémie Jacques

Dossier thématique : Immunosuppresseurs en hépato-gastroentérologie

Pré-test (p.1194-5)

Mise au point

Use of immunosuppressants in hepato-gastroenterology (p.1196-212)
Ariane Amoura, Antoine Hamon, Élise Mallart, Anthia Monribot, Andrea de La Selle, Geoffrey Rossi, Virginie Zarrouk, Victoire de Lastours, Agnès Lefort

Cas clinique

Complication of anti-TNF-alpha: a story with twists and turns (p.1213-8)
Ariane Amoura, Agnès Lefort

Revue bibliographique

Complications of immunosuppressants in hepatogastroenterology (p.1219-22)
Ariane Amoura, Antoine Hamon, Élise Mallart, Andrea de La Selle, Geoffrey Rossi, Virginie Zarrouk, Victoire de Lastours, Agnès Lefort

Entretien avec l’expert

Inflammatory bowel diseases’s treatment in 2022 (p.1223-5)
Xavier Treton

Post-test (p.1226-8)

BRÈVE D’HISTOIRE

The short history of surgery for anal abscesses and fistulas : everything has been tried... and it’s not over yet! (p.1229-38)
Vincent de Parades, Nadia Fathallah, Claude Parisot, Paul Benfredj

INJECTIONS DE RAPPEL

À retenir du n°9 Novembre 2022 (p.1239-41)